Portal de Periódicos da CAPES

Cardiac Pacing:

2004; Wiley; Volume: 27; Issue: 5 Linguagem: Inglês

10.1111/j.1540-8159.2004.00515.x

1540-8159

David L. Hayes, Seymour Furman,

Cardiovascular Syncope and Autonomic Disorders

Pacing and Clinical ElectrophysiologyVolume 27, Issue 5 p. 693-704 Cardiac Pacing: How It Started, Where We Are, Where We Are Going DAVID L. HAYES, DAVID L. HAYES Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York and the *Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Mayo College of Medicine, Rochester, MinnesotaSearch for more papers by this authorSEYMOUR FURMAN, SEYMOUR FURMAN Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York and the *Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Mayo College of Medicine, Rochester, MinnesotaSearch for more papers by this author DAVID L. HAYES, DAVID L. HAYES Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York and the *Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Mayo College of Medicine, Rochester, MinnesotaSearch for more papers by this authorSEYMOUR FURMAN, SEYMOUR FURMAN Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York and the *Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Mayo College of Medicine, Rochester, MinnesotaSearch for more papers by this author First published: 04 May 2004 https://doi.org/10.1111/j.1540-8159.2004.00515.xCitations: 22 Address for reprints: David L. Hayes, M.D., Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Mayo Medical School, 200 First Street, Rochester, MN 55905. E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Zoll PM. Resuscitation of the heart in ventricular standstill by external electric stimulation. N Engl J Med 1952; 247: 768– 771. 2 Zoll PM, Linenthal AJ, Norman LR, et al. Treatment of unexpected cardiac arrest by external electric stimulation of the heart. N Engl J Med 1956; 254: 541– 546. 3 Zoll PM, Linenthal AJ, Norman LR, Paul MH, Gibson W. Treatment of unexpected cardiac arrest by external electric stimulation of the heart. N Engl J Med 1956; 254: 541– 546. 4 Furman S. The early history of cardiac pacing. PACE 2003; 26: 2023– 2032. 5 Floresco N. Pince Excitatrice. J Physiol Path General 1905; 7: 785– 786. 6 Marmorstein M. Contribution a l'etude des excitation electriques localises sur le coeur en rapport avec la topographie de l'innervation du coeur chez le chien. [in French]J Physiol Path 1927; 25: 617– 625. 7 Lidwill MC. Cardiac disease in relation to anaesthesia. Proceedings of the Third Session, Australasian Medical Congress (British Medical Association) Sydney, Australia, September 2– 7, 1929. pp. 160. 8 Hyman AS. Resuscitation of the stopped heart by intracardial therapy. II Experimental use of an artificial pacemaker. Arch Intern Med 1932; 50: 283– 305. 9 Leatham A, Cook P, Davies JG. External electric stimulator for treatment of ventricular standstill. Lancet 1956; 2: 1185– 1189. 10 Glenn WWL, Mauro A, Longo E, et al. Remote stimulation of the heart by radio-frequency transmission. N Engl J Med 1959; 261: 948– 951. 11 Abrams LD, Hudson WA, Lightwood R. A surgical approach to the management of heart-block using an inductive coupled artificial cardiac pacemaker. Lancet 1960; 1: 1372– 1374. 12 Siddons AHM. Long-term artificial cardiac pacing: Experience in adults with heart block. Ann Roy Coll Surg Eng 1963; 32: 22– 41. 13 Chardack WM, Gage AA, Greatbatch W. A transistorized, self-contained implantable pacemaker for the long-term correction of complete heart block. Surgery 1960; 48: 643– 654. 14 Hunter SW, Roth NA. The platform bipolar myocardial electrode for prolonged treatment of total heart block. Lancet 1961; 81: 115– 117. 15 Zoll PM, Frank HA, Zarsky LR, et al. Long-term electrical stimulation of the heart for Stokes-Adams disease. Ann Surg 1961; 154: 330– 346. 16 Kantrowitz A, Cohen R, Raillard H, et al. The treatment of complete heart block with an implanted controllable pacemaker. Surg Gynec Obstet 1962; 115: 415– 420. 17 Ruben S, inventor. US Patent 2,422,045. 1947. 18 Greatbatch W, Lee JH, Mathias W, et al. The solid-state lithium battery: A new improved chemical power source for implantable cardiac pacemakers. IEEE Trans Biomed Eng 1971; 18: 317– 323. 19 Nathan DA, Center S, Wu C-Y, et al. An implantable synchronous pacemaker for the long term correction of complete heart block. Circulation 1963; 27: 682– 685. 20 Funke HD. Optimized sequential pacing of atria and ventricles: A new concept in treatment of bradycardiac dysrhythmias. [in German]Herz Kreislauf 1978; 10: 479– 483. 21 Aubert AE, Ector H. New lead technology for the 21st century. In GE Antonioli (ed.): Pacemaker Leads. Bologna , Italy , Monduzzi, 1997, pp. 17– 24. 22 Furman S. Pacemaker programmability. PACE 1978; 1: 161– 162. 23 Chardack WM, Gage AA, Federico AJ, et al. Five years' clinical experience with an implantable pacemaker: An appraisal. Surgery 1965; 58: 915– 922. 24 Kantrowitz A, Cohen R, Raillard H, et al. The treatment of complete heart block with an implanted controllable pacemaker. Surg Gynecol Obstet 1962; 115: 415– 420. 25 Parsonnet V, Cuddy TE, Escher DJW, et al. A pacemaker capable of external non-invasive programming. Trans Am Soc Artif Intern Organs 1973; 19: 224– 228. 26 Samet P, Bernstein WH, Nathan DA, et al. Atrial contribution to cardiac output in complete heart block. Am J Cardiol 1965; 16: 1– 10. 27 Benchimol A, Duenas A, Liggett MS, et al. Contribution of atrial systole to the cardiac function at a fixed and at a variable ventricular rate. Am J Cardiol 1965; 16: 11– 21. 28 Karlof I. Haemodynamic effect of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Med Scand 1975; 197: 195– 206. 29 Humen DP, Kostuk WJ, Klein GJ. Activity-sensing rate-responsive pacing: Improvement in myocardial performance with exercise. PACE 1985; 8: 52– 59. 30 Alt E, Heinz M, Hirgstetter C, et al. Control of pacemaker rate by impedance-based respiratory minute ventilation. Chest 1987; 92: 247– 252. 31 Rickards AF, Donaldson RM, Thalen HJ. The use of QT interval to determine pacing rate: Early clinical experience. PACE 1983; 6: 346– 356. 32 Mahaux V, Waleffe A, Kulbertus HE. Clinical experience with a new activity sensing rate modulated pacemaker using autoprogrammability. PACE 1990; 13: 819– 820. 33 Parsonnet V, Furman S, Smyth NPD. Implantable cardiac pacemakers. Status report and resource guideline: Pacemaker study grouop. Circulation 1974; 50: A-21– A-35. 34 Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code of antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. PACE 2002; 25: 260– 264. 35 Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106: 2145. 36 Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210. 37 Lamas GA, Orav EJ, Stambler BS, et al. Pacemaker selection in the elderly investigators: Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338: 1097. 38 Connolly SJ, Kerr CR, Gent M, et al. Canadian Trial of Physiologic Pacing Investigators: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342: 1385. 39 Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346: 1854. 40 Toff WD, Skehan JD, De Bono DP, et al. The United Kingdom Pacing and Cardiovascular Events (UKPACE) trial: United Kingdom Pacing and Cardiovascular Events. Heart 1997; 78: 221. 41 Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16– 20. 42 Sutton R, Brognole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy: A multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000; 102: 294– 299. 43 Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagalsyncope: Second vasovagal pacemaker study (VPS II): A randomized trial. JAMA 2003; 289: 2272– 2275. 44 Fananapazir L, Epstein ND, Curiel RV, et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731– 2742. 45 Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hyeprtrophic cardiomyopathy: A randomized, double-blind crossover trial. J Am Coll Cardiol 1997; 29: 435– 441. 46 Kappenberger L, Linde C, Daubert C, et al., and the PIC Study Group: Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997; 18: 1249– 1256. 47 Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obsgtructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999; 99: 2927– 2933. 48 Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 422– 424. 49 Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17: 1974– 1979. 50 Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation 2003; 108: 2596– 2603. 51 Auricchio A, Stellbrink C, Sack S. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39: 2026– 2033. 52 Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873– 880. 53 Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1902– 1905. 54 Young JB, Abraham JS, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003; 289: 2685– 2694. 55 Thackray S, Coletta A, Jones P, et al. Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001; 3: 491– 494. 56 Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 2000; 6: 276– 285. 57 Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): Rationale, design and end-points. Eur J Heart Fail 2001; 3: 481– 489. 58 Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003; 89: 54– 60. 59 Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40: 1140– 1150. 60 Carlson MD, Messenger J, Beau S, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) J Am Coll Cardiol 2003; 42: 627– 633. 61 Lee MA, Weachter R, Pollak S, et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency results of a randomized trial in patients with bradycardiac and atrial tachyarrhythmias. J Am Coll Cardiol 2003; 41: 1926– 1932. Citing Literature Volume27, Issue5May 2004Pages 693-704 ReferencesRelatedInformation